Source: Richard Craver, WINSTON-SALEM JOURNAL, 1/5/20
 

When Donald Trump was elected president in November 2016, an era of federal deregulation was projected for many industry sectors, particularly tobacco. The Trump administration Food and Drug Administration was expected to shift into lower gear, if not halt, its already slow-walking of asserting the regulatory authority given to it by a Democratic Congress in the 2009 Tobacco Control Act. Instead, in a stunning 13-day turn of events, the FDA accomplished two once-improbable goals sought by public-health and anti-tobacco advocacy groups:

For more of this story, click here.